About this initiative

Summary

In our globalised world, epidemics such as Ebola and Zika can spread quickly across borders and have dramatic impacts on human lives, the economy and global security. This Communication outlines a comprehensive EU strategy to support the Member States' capacity to prepare for and respond to such epidemics, to develop treatments and vaccines, and to coordinate with other efforts around the world.

Topic
Public health, Research and innovation
Type of act
Communication

Roadmap

Feedback: CLOSED
Type
Feedback period
26 March 2018 - 23 April 2018
View feedback received >
Download (254.3 KB - PDF - 3 pages)

Feedback (27)

  • European Public Health Alliance (Belgium)
    23 April 2018 Non-governmental organisation (NGO)
    European Public Health Alliance (Belgium)

    The European Public Health Alliance (EPHA), Europe’s largest public health umbrella organisation, welcomes the European Commission’s initiative to strengthen its activities related to global health security and public health emergency preparedness and response. In particular, we endorse the One Health approach of the Roadmap and would like to underline that, in a globalised world marked by international flows of trade and people, it is...

  • Comilva (Coordinamento del Movimento Italiano per la Libertà di Vaccinazione) (Italy)
    23 Aprile 2018 Other
    Comilva (Coordinamento del Movimento Italiano per la Libertà di Vaccinazione) (Italy)

    RILUTTANZA NEI CONFRONTI DEI VACCINI Lo scorso 7 Febbraio a Roma, in conferenza stampa da Palazzo Montecitorio, sono stati resi pubblici i risultati della IV COMMISSIONE PARLAMENTARE D’INCHIESTA SUI CASI DI MORTE E DI GRAVI MALATTIE CHE HANNO COLPITO IL PERSONALE MILITARE ITALIANO (…).
 Tra i fattori eziologici che hanno scatenato questa allarmante situazione spicca anche la profilassi vaccinale. La Commissione nell’ambito della sua attività...

  • Institut Mérieux (France)
    23 April 2018 Company/business organisation
    Institut Mérieux (France)

    Institut Mérieux, the French-based holding of the Mérieux group, lends its experience in industrial biology to the service of medicine and public health across the globe. In order to combat infectious diseases and cancers, it devises and develops complementary solutions in the fields of diagnostics, immunotherapy, food safety and nutrition. Through its 3 bio-industrial companies, bioMérieux (world leader in clinical and industrial microbiology...

All feedback (27) >

Commission adoption

Type

Communication
More about adopted acts

Subscribe to receive notifications

Be notified by email when new initiatives are added on topics you're interested in or follow developments to individual initiatives.
You won't receive more than 1 email per day and you can manage your subscription preferences whenever you like.
Simply create an account using the Register button below.